-transparent.png){kind=logo}
In transgenic mice bearing a murine immunoglobulin enhancer/c-myc fusion transgene (Emu-myc), it was found that antisense DNA methylphosphonates targeted against c-myc mRNA inhibited production of c-MYC protein in peripheral lymphocytes. The decrease in protein was measured 3-4 h after i.v. administration of a 300-nmol dose. c-MYC was detected by immunofluorescence of fixed cells stained with an anti-c-MYC antiserum. In addition, DNA methylphosphonates did not induce acute toxicity following i.v. administration of a 300-nmol dose. An identically administered scrambled sequence oligomer did not decrease c-MYC protein or induce toxicity. Finally, recovery of DNA methylphosphonates from the blood plasma of treated mice indicated that the oligomers remained intact up to 3 h, while their concentrations decreased rapidly for the first h, then slowly decreased over the next 2 h. This is the first demonstration of sequence-specific antisense DNA methylphosphonate inhibition of gene expression in the bloodstream of an animal model.
E Wickstrom, and
T A Bacon, and
E L Wickstrom
January 1988,
Current topics in microbiology and immunology,
E Wickstrom, and
T A Bacon, and
E L Wickstrom
August 2008,
Oncogene,
E Wickstrom, and
T A Bacon, and
E L Wickstrom
January 1989,
Haematology and blood transfusion,
E Wickstrom, and
T A Bacon, and
E L Wickstrom
August 1989,
Oncogene,
E Wickstrom, and
T A Bacon, and
E L Wickstrom
December 1989,
Molecular biology & medicine,
E Wickstrom, and
T A Bacon, and
E L Wickstrom
May 1993,
Pathologie-biologie,
E Wickstrom, and
T A Bacon, and
E L Wickstrom
July 1994,
Biochemical pharmacology,
E Wickstrom, and
T A Bacon, and
E L Wickstrom
September 1995,
Research communications in molecular pathology and pharmacology,
E Wickstrom, and
T A Bacon, and
E L Wickstrom
June 1990,
Molecular and cellular biology,
E Wickstrom, and
T A Bacon, and
E L Wickstrom
August 1996,
Cancer letters,
